See more : Delixi Xinjiang Transportation Co.,Ltd. (603032.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Selvita S.A. (SLV.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Selvita S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- MicroPort Scientific Corporation (0853.HK) Income Statement Analysis – Financial Results
- Yamato Holdings Co., Ltd. (YATRY) Income Statement Analysis – Financial Results
- Konami Group Corporation (9766.T) Income Statement Analysis – Financial Results
- Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret A.S. (BRISA.IS) Income Statement Analysis – Financial Results
- PT Aneka Gas Industri Tbk (AGII.JK) Income Statement Analysis – Financial Results
Selvita S.A. (SLV.WA)
About Selvita S.A.
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 346.96M | 407.46M | 310.92M | 137.36M | 30.44M | 70.68M | 54.57M | 48.13M | 41.03M |
| Cost of Revenue | 71.16M | 68.39M | 91.13M | 21.00M | 25.13M | 10.94M | 8.16M | 13.35M | 11.57M |
| Gross Profit | 275.80M | 339.07M | 219.79M | 116.35M | 5.31M | 59.74M | 46.41M | 34.78M | 29.45M |
| Gross Profit Ratio | 79.49% | 83.21% | 70.69% | 84.71% | 17.44% | 84.52% | 85.04% | 72.26% | 71.79% |
| Research & Development | 0.00 | 7.40M | 6.01M | 0.00 | 0.00 | 4.65M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 44.18M | 19.99M | 0.00 | 13.21M | 10.02M | 10.54M | 8.76M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.90M | 9.43M | 44.18M | 19.99M | 1.24M | 13.21M | 10.02M | 10.54M | 8.76M |
| Other Expenses | 206.49M | 294.29M | 149.04M | 76.81M | -234.29K | 295.00 | 225.00 | 168.00 | 79.00 |
| Operating Expenses | 211.38M | 294.29M | 193.22M | 96.81M | 1.48M | 48.59M | 39.68M | 41.97M | 27.32M |
| Cost & Expenses | 282.54M | 362.69M | 284.36M | 117.81M | 26.61M | 59.53M | 47.84M | 55.32M | 38.89M |
| Interest Income | 512.00K | 4.00K | 13.93K | 12.83K | 19.34K | 158.64K | 31.15K | 283.78K | 612.76K |
| Interest Expense | 11.83M | 4.20M | 3.80M | 627.93K | 53.06K | 93.94K | 47.95K | 41.30K | 31.52K |
| Depreciation & Amortization | 45.45M | 35.48M | 27.49M | 13.53M | 2.63M | 4.53M | 3.23M | 3.62M | 3.43M |
| EBITDA | 125.61M | 75.39M | 52.43M | 33.01M | 7.58M | 15.67M | 8.46M | 2.38M | 6.29M |
| EBITDA Ratio | 36.20% | 19.94% | 16.99% | 24.03% | 21.24% | 23.15% | 15.56% | -7.47% | 15.47% |
| Operating Income | 69.31M | 44.78M | 26.08M | 19.54M | 3.84M | 11.13M | 6.70M | -1.21M | 2.07M |
| Operating Income Ratio | 19.98% | 10.99% | 8.39% | 14.23% | 12.60% | 15.75% | 12.28% | -2.52% | 5.05% |
| Total Other Income/Expenses | -2.11M | -4.82M | -5.02M | -690.30K | 1.06M | 583.74K | -1.52M | -69.19K | 747.84K |
| Income Before Tax | 67.20M | 40.21M | 21.07M | 18.85M | 4.89M | 11.72M | 5.18M | -1.28M | 2.82M |
| Income Before Tax Ratio | 19.37% | 9.87% | 6.78% | 13.73% | 16.08% | 16.58% | 9.49% | -2.67% | 6.88% |
| Income Tax Expense | -2.68M | 7.60M | 2.85M | -1.07M | -909.98K | 220.20K | 930.13K | -3.97M | -3.41M |
| Net Income | 69.88M | 30.31M | 14.90M | 18.00M | 5.52M | 10.50M | 3.93M | 2.72M | 6.27M |
| Net Income Ratio | 20.14% | 7.44% | 4.79% | 13.10% | 18.14% | 14.85% | 7.19% | 5.65% | 15.28% |
| EPS | 3.81 | 0.02 | 0.80 | 1.05 | 1.05 | 0.66 | 0.24 | 0.17 | 0.39 |
| EPS Diluted | 3.81 | 0.02 | 0.80 | 1.05 | 1.05 | 0.65 | 0.24 | 0.17 | 0.39 |
| Weighted Avg Shares Out | 18.36M | 18.36M | 18.36M | 17.21M | 5.26M | 15.81M | 16.10M | 16.10M | 16.10M |
| Weighted Avg Shares Out (Dil) | 18.36M | 18.36M | 18.36M | 17.21M | 5.26M | 16.10M | 16.10M | 16.10M | 16.10M |
Source: https://incomestatements.info
Category: Stock Reports